Showing 2,658 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

PrEP

OPINION: Our post-PrEP world needs a reality check

Editor's pick
Same Same
29 March 2016
Pharmaceutical industry

Merck Wins Chance for Royalties on Gilead’s Hepatitis C Cure

Editor's pick
Bloomberg
24 March 2016
HIV testing policies & guidelines

Opt-out HIV/HBV/HCV testing for patients attending emergency departments identifies significant number of new infections

News
22 March 2016
Hepatitis C treatment

Opioid Substitutes Do Not Impede Hep C Combo Drugs

Editor's pick
Medscape
18 March 2016
Hepatitis & HIV

Starting HIV therapy associated with improvements in liver function, especially when viral load is suppressed

News
17 March 2016
Cardiovascular disease

HIV-related factors increase risk of stroke

News
15 March 2016
Drug interactions & pharmacokinetics

Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals

News
14 March 2016
Hepatitis C treatment

US: VA expands hepatitis C treatment to all patients with the virus

Editor's pick
Military Times
11 March 2016
Pharmaceutical industry

Inside the $100 million ad blitz for a $1100-a-pill drug for hepatitis C

Editor's pick
STAT
9 March 2016
People who inject drugs

Indiana HIV epidemic among people who inject drugs is controlled, but ongoing vigilance is needed

News
9 March 2016
Hepatitis C treatment

Hepatitis medicines: Warning concerning Harvoni® packs with counterfeit contents

Editor's pick
Swiss Agency for Therapeutic Products
8 March 2016
Hepatitis & HIV

More than 2 million people co-infected with HIV and hepatitis C

Editor's pick
Eurekalert Inf Dis
8 March 2016
Hepatitis C treatment

20,000 Georgians to Receive Free Hepatitis C Treatment

Editor's pick
Georgia Today
8 March 2016
Pharmaceutical industry

Gilead Spars With Merck Over Hepatitis C $1000-Pill Royalties

Editor's pick
Bloomberg
8 March 2016
New & experimental hepatitis C treatment

Ravidasvir plus sofosbuvir demonstrates high cure rate for people with hepatitis C genotype 4

News
8 March 2016
Hepatitis C treatment

New York Said to Probe Insurers Over Hepatitis C Drugs

Editor's pick
Bloomberg
4 March 2016
Access to healthcare

His Job Is to Sell a $1,000 Pill for $10 Without Losing Money

Editor's pick
Bloomberg
29 February 2016
Treatment outcomes & life expectancy

Life expectancy in HIV-positive people in the US still lags 13 years behind HIV-negative people

News
28 February 2016
Hepatitis C treatment

Sofosbuvir/ledipasvir for 6 weeks cures HCV in HIV-positive people with acute HCV if viral load is low

News
26 February 2016
Hepatitis C treatment

New recommendations in the updated WHO guidelines for the screening, care and treatment of persons with chronic hepatitis C infection

Editor's pick
World Health Organization
25 February 2016
People who inject drugs

Should we focus hepatitis C treatment on some injectors and not others?

Editor's pick
Drug & Alcohol Findings
22 February 2016
Hepatitis B

Survey shows more than 800,000 people in US have hepatitis B, half of them Asian

News
22 February 2016
Hepatitis C symptoms & diagnosis

Direct-acting antivirals reduce cryoglobulinemia in hepatitis C

News
19 February 2016
Pharmaceutical industry

The cost of curing Hepatitis C

Editor's pick
BBC Newsnight / You Tube
18 February 2016